At the Board of Directors' meeting held on May 15, 2023, the Alfresa Holdings Corporation resolved to change its Representative Directors, as follows. Furthermore, Alfresa Holdings Corporation plans to formally decide this matter at the 20th Ordinary General Meeting of Shareholders, which will be held on June 27, 2023, and at the Board of Directors' meeting held thereafter. 1. Reason for new appointments Amid changes in the business environment, the Company aims to strengthen its
management structure by switching to a system of three Representative Directors in order to improve corporate value. 2. Appointments of Representative Directors New title Representative Director & Deputy President Assistant to the President (General Affairs, Financial Planning, Corporate Communication, and
Compliance) Current title: Director & Deputy PresidentAssistant to the President (General Affairs, Financial Planning, Corporate Communication, and Compliance). Name" Seiichi Kishida. Name Seiichi Kishida. New title: Representative Director & Deputy President (Ethical Pharmaceuticals Wholesaling Business and Total Supply Chain Services) Current title: Director & Deputy President (Ethical Pharmaceuticals Wholesaling Business and Total Supply Chain Services) Name: Yusuke Fukujin.